| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Platform: GPL24247
|
RESULTS
|
||||||
| GSE207163 |
Transcriptional repression by a secondary DNA binding surface of DNA topoisomerase I safeguards against hypertranscription
|
62 | Zhenhua hu | May 29, 2023 | ||||
| GSE254197 |
Expression changes in Setdb1-knockdown with shRNA in Hepa1-6 cells, a mouse hepatocellular carcinoma line
|
4 |
|
Yosuke Igarashi | Dec 08, 2024 | |||
| GSE240505 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [RNA-seq]
|
22 |
|
Hongjian Jin | Mar 04, 2024 | |||
| GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
26 |
|
Hongjian Jin | Mar 02, 2024 | |||
| GSE240980 |
Cellular fitness of MYC-driven cancer cells to genetic and pharmacologic perturbations in normoxia, hypoxia and 3D
|
8 |
|
Hongjian Jin | Jun 26, 2024 | |||
| GSE251918 |
Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations [RNA-seq]
|
8 |
|
Hongjian Jin | Jun 05, 2025 | |||
| GSE251920 |
Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations
|
18 |
|
Hongjian Jin | Jun 05, 2025 | |||
| GSE253185 |
Credentialling a c-MYC-driven genetic neuroblastoma model
|
5 |
|
Hongjian Jin | Nov 05, 2024 | |||
| GSE255205 |
Credentialling a c-MYC-driven genetic neuroblastoma model [RNAseq-NB]
|
14 |
|
Hongjian Jin | Nov 05, 2024 | |||
| GSE273448 |
Ad-SGE-DKK3 Gene Therapy Against Resistance to Immune Checkpoint Blockade in Malignant Mesothelioma
|
6 |
|
Sung Wook Kang | Jul 30, 2024 | |||
| GSE185884 |
Three-dimensional analysis of genome organization in CTCF-WT and CTCF-KO dendritic cells
|
92 | Hyoung-Pyo Kim | Jan 04, 2023 | ||||
| GSE229222 |
Glutamine antagonist JHU083 reprograms immunosuppressive tumor-associated macrophages to drive tumor immunity in urologic cancers, bulk RNA-seq
|
12 |
|
Alex Jea-Eun Lee | May 18, 2024 | |||
| GSE230162 |
Glutamine antagonist JHU083 reprograms immunosuppressive tumor-associated macrophages to drive tumor immunity in urologic cancer
|
24 |
|
Alex Jea-Eun Lee | May 17, 2024 | |||
| GSE229198 |
Tonic type 2 immunity controls autoimmunity in the skin
|
12 |
|
Haeseung Lee | Apr 08, 2024 | |||
| GSE168258 |
Identification and isolation of hematopoietic stem and progenitor cell populations (RNA-seq)
|
8 |
|
Jens Lichtenberg | Mar 03, 2023 | |||
| GSE168260 |
Identification and isolation of hematopoietic stem and progenitor cell populations
|
21 | Jens Lichtenberg | Mar 03, 2023 | ||||
| GSE224128 |
Effect of extracellular RNase digestion on cellular RNA from neutrophils and GlycoRNA sequences of neutrophils
|
13 |
|
Jun Lu | Jan 22, 2024 | |||
| GSE297286 |
Hypercapnia induces long-term DNA methylation changes in skeletal muscle.
|
50 |
|
Andy Madrid | May 20, 2025 | |||
| GSE188543 |
Pegvisomant-treated mouse prostate epithelium renal grafts
|
6 |
|
Paul Marker | Apr 01, 2022 | |||
| GSE197640 |
Tamoxifen-induced Ghr deletion in WT mouse prostates
|
5 |
|
Paul Marker | Jan 01, 2023 |
